| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 0.000 | 20140625, Armentia A
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 10.460 | 20101214, Gadisseur R
| | 1.10 - Any allergy symptom, Diagnosed | 2011 | Italy | IgE | 786 | 18.600 | 20110902, Gadermaier G
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 1.300 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 19.400 | 20140625, Armentia A
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 8.570 | 20130605, Simon D
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 4.170 | 20120528, Patelis A
| | 1.4 - Respiratory Symptoms, Diagnosed | 2012 | France | IgE | 129 | 5.400 | 20121204, Caimmi D
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 15.000 | 20091005, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 12.000 | 20140821, Choi JS
| | 1.8 - Fruit Allergy | 2012 | Spain | IgE | 212 | 36.000 | 20120912, Palacin A
| | 1.9 - Pollen Allergy | 2014 | Czech Republic | IgE | 826 | 4.600 | 20140606, Panzner P
| | 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 4.000 | 20140625, Armentia A
| | 1.9 - Pollen Allergy | 2012 | Spain | IgE | 117 | 13.000 | 20120912, Palacin A
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 3.1.1 - Source Sensitized (SPT) | 2002 | Spain | SPT | 20 | 40.000 | 2002, Garcia-Selles FJ
| | 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 3.000 | 20111214, Zheng YW
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2013 | China | IgE | 38 | 44.700 | 20130624, Ma S
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2010 | China | IgE | 17 | 88.250 | 20101229, Han D
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2010 | China | IgE | 13 | 76.920 | 20101229, Han D
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Italy | IgE | 26 | 46.150 | 20091204, Ciardiello MA
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 15.000 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2013 | China | IgE | 49 | 51.000 | 20130624, Ma S
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2011 | Italy | IgE | 431 | 42.230 | 20111123, Bernardi ML
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 10.810 | 20090826, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2008 | Canada | IgE | 10 | 30.000 | 20081010, Gadermaier G
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2014 | Spain | IgE | 130 | 85.800 | 20140401, Armentia A
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 55 | 30.900 | 20120726, Pedrosa M
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Spain | IgE | 11 | 81.810 | 20110701, Tordesillas L
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Spain | IgE | 9 | 55.550 | 20110701, Tordesillas L
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Spain | IgE | 4 | 50.000 | 20110701, Tordesillas L
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Spain | IgE | 8 | 37.500 | 20091217, Palacin A
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2006 | Spain | SPT | 14 | 85.700 | 20060401, Palacin A
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2002 | Spain | SPT | 47 | 36.200 | 2002, Garcia-Selles FJ
| | 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2013 | Austria | IgE | 32 | 18.750 | 20130805, Vejvar E
| | 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 68 | 13.200 | 20120726, Pedrosa M
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 4.040 | 20110223, De Knop KJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2013 | China | IgE | 17 | 88.240 | 20130510, Ma S
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | China | IgE | 63 | 66.660 | 20120903, Gao ZS
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2010 | China | IgE | 44 | 72.720 | 20101229, Han D
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Austria | IgE | 9 | 88.890 | 20081010, Gadermaier G
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2004 | Spain | IgE | 24 | 83.300 | 20040907, Lombardero M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2002 | Italy | IgE (IB) | 17 | 35.300 | 2002b, Pastorello EA
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2004 | Spain | SPT | 24 | 70.800 | 20040907, Lombardero M
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 2.160 | 20120528, Patelis A
|
|
Loading...
Art v 3
